These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7547433)

  • 1. The characterization of a rabbit model of inflammatory bowel disease.
    Anthony D; Savage F; Sams V; Boulos P
    Int J Exp Pathol; 1995 Jun; 76(3):215-24. PubMed ID: 7547433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
    De Vry CG; Prasad S; Komuves L; Lorenzana C; Parham C; Le T; Adda S; Hoffman J; Kahoud N; Garlapati R; Shyamsundar R; Mai K; Zhang J; Muchamuel T; Dajee M; Schryver B; McEvoy LM; Ehrhardt RO
    Gut; 2007 Apr; 56(4):524-33. PubMed ID: 16950831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of experimental acute ulcerative colitis in rats by administration of dextran sulfate sodium at low concentration followed by intracolonic administration of 30% ethanol.
    Chen Y; Si JM; Liu WL; Cai JT; Du Q; Wang LJ; Gao M
    J Zhejiang Univ Sci B; 2007 Sep; 8(9):632-7. PubMed ID: 17726744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
    Kullmann F; Arndt H; Gross V; Rüschoff J; Schölmerich J
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1205-11. PubMed ID: 9471027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The establishment of TNBS-induced experimental colitis].
    Zhu F; Qian J; Pan G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):271-8. PubMed ID: 11367691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal model: immunologic model of inflammatory bowel disease.
    Rabin BS
    Am J Pathol; 1980 Apr; 99(1):253-6. PubMed ID: 7361861
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.
    Hogaboam CM; Vallance BA; Kumar A; Addison CL; Graham FL; Gauldie J; Collins SM
    J Clin Invest; 1997 Dec; 100(11):2766-76. PubMed ID: 9389741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hapten-induced model of chronic inflammation and ulceration in the rat colon.
    Morris GP; Beck PL; Herridge MS; Depew WT; Szewczuk MR; Wallace JL
    Gastroenterology; 1989 Mar; 96(3):795-803. PubMed ID: 2914642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of pycnogenol in experimental inflammatory bowel diseases.
    Mochizuki M; Hasegawa N
    Phytother Res; 2004 Dec; 18(12):1027-8. PubMed ID: 15742344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats.
    Prakash A; Medhi B; Avti PK; Saikia UN; Pandhi P; Khanduja KL
    Phytother Res; 2008 Nov; 22(11):1511-9. PubMed ID: 18688794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats.
    Prakash O; Medhi B; Saikia UN; Pandhi P
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):9-16. PubMed ID: 18598295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators.
    Abdolghaffari AH; Baghaei A; Moayer F; Esmaily H; Baeeri M; Monsef-Esfahani HR; Hajiaghaee R; Abdollahi M
    Hum Exp Toxicol; 2010 Apr; 29(4):287-95. PubMed ID: 20144954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective influence of oxypurinol on the trinitrobenzene sulfonic acid(TNB) model of inflammatory bowel disease in rats.
    Siems WG; Grune T; Werner A; Gerber G; Buntrock P; Schneider W
    Cell Mol Biol; 1992 Apr; 38(2):189-99. PubMed ID: 1571948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.
    Leach MW; Bean AG; Mauze S; Coffman RL; Powrie F
    Am J Pathol; 1996 May; 148(5):1503-15. PubMed ID: 8623920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study the effect and mechanism of thalidomide in model of inflammatory bowed disease].
    Wang X; Ouyang Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):548-51. PubMed ID: 16078585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis.
    Mencarelli A; Distrutti E; Renga B; Cipriani S; Palladino G; Booth C; Tudor G; Guse JH; Hahn U; Burnet M; Fiorucci S
    Eur J Pharmacol; 2011 Aug; 665(1-3):29-39. PubMed ID: 21554873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases].
    Pytrus T; Mowszet K; Krzesiek E; Rzeszutko M; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):460-4. PubMed ID: 19205374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.